FDA releases draft guideline related to nanotechnology

The Food and Drug Administration (FDA) has released “Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology,” a draft guidance document available for comment. The goal is “to provide regulated industries with greater certainty about the use of nanotechnology. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here